Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Sodium valproate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sodium valproate 200mg/ml oral solution
0408010W0AACACA
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
|
Sodium valproate 20mg/5ml oral solution
0408010W0AABKBK
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
|
Sodium valproate 600mg/5ml oral solution
0408010W0AABEBE
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
|
Sodium valproate 60mg/5ml oral solution
0408010W0AABIBI
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
|
Sodium valproate 60mg/5ml oral suspension
0408010W0AACBCB
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
|
Sodium valproate 75mg/5ml oral solution
0408010W0AABLBL
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
|
Sodium valproate 90mg/5ml oral solution
0408010W0AABFBF
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.